​An accomplished and senior life science’s professional advisor with over 30 years’ experience deploying significant expertise in taking early-stage companies forward through to commercial maturity. 
 
Appointed to numerous Chairman, Board and CEO positions in start-up companies through to NASDAQ listings. Provided significant commercialisation and commercial advancement contributions to the health care industry. Such contributions have included providing expert advisory to pharma, diagnostics and life sciences companies. Previous engagements include Novartis Diagnostics, EPIX Pharmaceuticals, Tyrogenex and Booz, Allen & Hamilton.